Chemistry Controls, Calibrators and Reagents
Sigma Aldrich Fine Chemicals Biosciences L-(-)-Glucose >=99% | 921-60-8 | MFCD00148913 | 500MG
L-(-)-Glucose >=99% | Purity: >=99% | Mol Wt: 180.16 | 921-60-8 | MFCD00148913 | 500MG
Sigma Aldrich Fine Chemicals Biosciences L-(-)-Glucose >=99% | 921-60-8 | MFCD00148913 | 25G
L-(-)-Glucose >=99% | Purity: >=99% | Mol Wt: 180.16 | 921-60-8 | MFCD00148913 | 25G
Medchemexpress LLC MCC-AAQ-Exa | 3052836-65-1 | 95.3% | 924.97 | C47H53FN8O11 | 5 MG
MCC-AAQ-Exa is a drug-linker conjugate used in the development of antibody-drug conjugates (ADCs). It is produced by condensing an MCC maleimide-containing linker with an exatecan payload and is supplied as a research reagent for conjugation workflows.
- Drug-linker conjugate for antibody-drug conjugate (ADC) development.
- Contains an MCC maleimide linker enabling thiol conjugation to antibodies.
- Derived from exatecan payload for potent cytotoxic activity once internalized.
- Molecular weight 924.97.
- Chemical formula C47H53FN8O11.
- Purity 95.3% (as supplied).
- CAS number 3052836-65-1.
- Recommended storage: -20°C, protect from light, stored under inert gas; in solvent: -80°C up to 6 months, -20°C up to 1 month.
Abcam L-AP4, group III mGlu agonist, 10MG
MW 183.1 Da, Purity >99%. Selective group III mGlu agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-AP5, NMDA glutamate site antagonist, 100MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. More active form of DL-AP5.
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-AP4, group III mGlu agonist, 50MG
MW 183.1 Da, Purity >99%. Selective group III mGlu agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-AP5, NMDA glutamate site antagonist, 1MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. More active form of DL-AP5.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP5, NMDA glutamate site antagonist, 100MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. Also available as the sodium salt (ab120271).
The product is subject to the following: Abcam Restricted Use Statement
ELITechGroup Sweat Controls, L1, L2, L3, 12 ea, 36x0.75mL
Each Sweat control has a different molarity. Sweat Control 1 is approximately 40mmol/L, Sweat Control 2 is approximately 70mmol/L, and Sweat Control 3 is approximately 130mmol/L.
